Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T06:29:03.275Z Has data issue: false hasContentIssue false
  • English
  • Français

The epidemiology of carbapenem resistant Enterobacter spp: A case–case–control matched analysis

Published online by Cambridge University Press:  24 November 2020

Leore Cohen Mendel Open the ORCID record for Leore Cohen Mendel [Opens in a new window] ,
Keren Amity ,
David E. Katz ,
Tsilia Lazarovitch ,
Ronit Zaidenstein  and
Dror Marchaim
Leore Cohen Mendel
Affiliation:
Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel
Keren Amity
Affiliation:
Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel
David E. Katz
Affiliation:
Division of Internal Medicine, Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel
Tsilia Lazarovitch
Affiliation:
The Microbiology Laboratory, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel
Ronit Zaidenstein
Affiliation:
Department of Medicine A, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Dror Marchaim*
Affiliation:
Unit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
*
Author for correspondence: Dror Marchaim, MD, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

A case–case–control investigation (216 patients) examined the risk factors and outcomes of carbapenem-resistant Enterobacter (CR-En) acquisition. Recent exposure to fluoroquinolones, intensive care unit (ICU) stay, and rapidly fatal McCabe condition were independent predictors for acquisition. Acquiring CR-En was independently associated with discharge to a long-term care facility after being admitted from home.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 42 , Issue 6 , June 2021 , pp. 754 - 759
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: Some of the information pertaining to patients with CR-En which was included in this publication, was also retrieved for a study previously published as Lazarovitch T, Amity K, Coyle JR, et al. The complex epidemiology of carbapenem-resistant enterobacter infections: a multicenter descriptive analysis. Infect Control Hosp Epidemiol 2015;36:1283–1291.

References

Lazarovitch, T, Amity, K, Coyle, JR, et al. The complex epidemiology of carbapenem-resistant enterobacter infections: a multicenter descriptive analysis. Infect Control Hosp Epidemiol 2015;36:1283–1291.CrossRefGoogle ScholarPubMed
WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization website. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Published April 14, 2017. Accessed October 1, 2020.Google Scholar
Marchaim, D, Chopra, T, Perez, F, et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol 2011;32:861–71.CrossRefGoogle ScholarPubMed
Leclercq, R, Cantón, R, Brown, DFJ, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013;19:141–60.CrossRefGoogle ScholarPubMed
Kaye, KS, Harris, AD, Samore, M, Carmeli, Y. The case–case–control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 2005;26:346–351.CrossRefGoogle ScholarPubMed
Types of healthcare-associated infections. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/infectiontypes.html. Updated March 2014. Accessed October 29, 2020.Google Scholar
Charlson, ME, Pompei, P, Ales, KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.CrossRefGoogle ScholarPubMed
Bion, JF, Edlin, SA, Ramsay, G, et al. Validation of a prognostic score in critically ill patients undergoing transport. Br Med J (Clin Res Ed) 1985;291:432–434.CrossRefGoogle ScholarPubMed
Katz, S, Ford, AB, Moskowitz, RW, Jackson, BA, Jaffe, MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.CrossRefGoogle ScholarPubMed
Fuzi, M, Rodriguez Baño, J, Toth, A. Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents. Front Microbiol 2020;11:271.CrossRefGoogle ScholarPubMed